Literature DB >> 29607005

The antipsychotic landscape: dopamine and beyond.

Paul D Morrison1, Robin M Murray2.   

Abstract

Until recently, the actions of antipsychotic and pro-psychotic drugs have largely been evaluated in the framework of neuronal doctrine - namely, that neurons communicate by releasing transmitters, and that psychiatric disorders are caused by neurotransmitter imbalances. Moreover, the majority of studies have focused on single transmitter systems - neglecting the fact that in the nervous system, different transmitter systems work in concert and impact on not only their immediate receptors but also downstream pathways that shape structural plasticity. In this review, we discuss the history of understanding the antipsychotic and pro-psychotic actions of drugs, recent developments and future perspectives.

Entities:  

Keywords:  NMDA channels; antipsychotics; cannabinoids; dopamine; nitric oxide; schizophrenia; serotonin

Year:  2018        PMID: 29607005      PMCID: PMC5846922          DOI: 10.1177/2045125317752915

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  59 in total

1.  Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation.

Authors:  Anthony C Vernon; Sridhar Natesan; William R Crum; Jonathan D Cooper; Michel Modo; Steven C R Williams; Shitij Kapur
Journal:  Biol Psychiatry       Date:  2012-01-15       Impact factor: 13.382

Review 2.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.

Authors:  Franz X Vollenweider; Michael Kometer
Journal:  Nat Rev Neurosci       Date:  2010-08-18       Impact factor: 34.870

Review 3.  Memories of NMDA receptors and LTP.

Authors:  G L Collingridge; T V Bliss
Journal:  Trends Neurosci       Date:  1995-02       Impact factor: 13.837

Review 4.  A new intellectual framework for psychiatry.

Authors:  E R Kandel
Journal:  Am J Psychiatry       Date:  1998-04       Impact factor: 18.112

Review 5.  The big data challenges of connectomics.

Authors:  Jeff W Lichtman; Hanspeter Pfister; Nir Shavit
Journal:  Nat Neurosci       Date:  2014-10-28       Impact factor: 24.884

Review 6.  Spine Dynamics: Are They All the Same?

Authors:  Kalen P Berry; Elly Nedivi
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

7.  Classics revisited. Uber Coca. By Sigmund Freud.

Authors: 
Journal:  J Subst Abuse Treat       Date:  1984

Review 8.  The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond.

Authors:  Darrick T Balu; Joseph T Coyle
Journal:  Curr Opin Pharmacol       Date:  2014-12-23       Impact factor: 5.547

9.  The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.

Authors:  J M Stone; P D Morrison; I Koychev; F Gao; T J Reilly; M Kolanko; A Mohammadinasab; S Kapur; P K McGuire
Journal:  Psychol Med       Date:  2016-09-22       Impact factor: 7.723

Review 10.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Authors:  S Navari; P Dazzan
Journal:  Psychol Med       Date:  2009-04-02       Impact factor: 7.723

View more
  8 in total

1.  A tetrahydrobiopterin deficit finding in schizophrenia: A confirmation study.

Authors:  James D Clelland; Jennifer Smeed; Serge Cremers; Catherine L Clelland
Journal:  Schizophr Res       Date:  2019-06-21       Impact factor: 4.939

Review 2.  α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future.

Authors:  Alvin V Terry; Patrick M Callahan
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

3.  Ideology over evidence?

Authors:  Sameer Jauhar; Allan H Young
Journal:  BJPsych Bull       Date:  2018-06

4.  Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics.

Authors:  Hélène Gréa; Delphine Bouchet; Véronique Rogemond; Nora Hamdani; Emmanuel Le Guen; Ryad Tamouza; Estelle Darrau; Christine Passerieux; Jérôme Honnorat; Marion Leboyer; Laurent Groc
Journal:  Front Psychiatry       Date:  2019-09-13       Impact factor: 4.157

5.  Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
.

Authors:  Paul D Morrison; Robin M Murray
Journal:  Dialogues Clin Neurosci       Date:  2020-09       Impact factor: 5.986

Review 6.  Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia.

Authors:  Nina Vanessa Kraguljac; Adrienne Carol Lahti
Journal:  Front Psychiatry       Date:  2021-03-11       Impact factor: 5.435

7.  Enter the plague.

Authors:  Joel R Keep
Journal:  Int J Ment Health Nurs       Date:  2021-08-13       Impact factor: 3.503

Review 8.  The neural substrates of neurological soft signs in schizophrenia: a systematic review.

Authors:  Genelle D Samson; Adrienne C Lahti; Nina V Kraguljac
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.